Board-recruited to lead the operational and strategic turnaround of an iconic color cosmetics brand; eliminated $5M+ in aged inventory and reduced days-on-hand from >450 to <250.
•
Cut freight spend by 30% and airfreight reliance by 70%; migrated 3PL to optimize pick-face, execution, and workforce cost efficiency.
•
Shifted Amazon from Vendor Central to Seller Central, improving net product margins by 7% in the brand's fastest-growing channel.
•
Realigned contract manufacturing away from 85% single-source dependency, reducing 2025 tariff exposure by ~30% and overall COGS by 6%.
•
Implemented eQMS, S&OP (improving MAPE by 10%), and a Stage Gate NPD process — increasing launch transparency and accountability.
•
Exceeded UFR targets (98.2% vs. 97% goal) while navigating shrinking markets and viral TikTok demand spikes; redesigned NPD launch strategy to absorb viral opportunities.
Key executive partner in PE-supported scale-up of a modern wellness brand with DTC, Amazon, and retail channels.
Directed NetSuite ERP implementation and AI-driven planning stack (SourceDay, NetStock); reduced inventory carry cost by $7.2M.
Achieved 24% reduction in COGS through strategic renegotiation of manufacturing contracts while maintaining supply chain resilience.
Drove 15% YOY topline growth by influencing marketing, channel mix, and product strategy — including the pivot to women's health.
Consolidated PMO into a unified center, increasing project commercialization by 25% and aligning cross-functional execution.
Reduced liability reserves by $1.65M through cost-effective supply chain solutions.
Spearheaded M&A diligence and integration efforts, including a large-scale acquisition to enhance strategic positioning.
Shifted hero product (Vivix) into gummy format to expand market base; led ESG-aligned reformulations and packaging redesign.
Achieved 20% reduction in lead times, 15% improvement in on-time deliveries, and 17% gain in forecast accuracy.
Implemented Stage Gate and global S&OP processes; reduced facility costs by 15%.
Directed FDA/MDSAP compliance, ERP upgrades, and packaging transitions during COVID-era supply chain volatility.
Opened EU and Asian markets through accelerated regulatory approval and adapted go-to-market strategies.
Re-engineered warehouse operations, improving product flow and inventory management.
